Assetmark, Inc
- SEC CIK
- 0001344551
- Latest filing
- Jul 30, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −2,325−100.0% | Sold out | Holders |
| Q3 2023 | 2,325 | $5.49K | <0.1% | +451+24.1% | Added | Holders |
| Q2 2023 | 1,874 | $11.8K | <0.1% | +216+13.0% | Added | Holders |
| Q1 2023 | 1,658 | $9.57K | <0.1% | +547+49.2% | Added | Holders |
| Q4 2022 | 1,111 | $11.4K | <0.1% | +359+47.7% | Added | Holders |
| Q3 2022 | 752 | $13.0K | <0.1% | +110+17.1% | Added | Holders |
| Q2 2022 | 642 | $9.00K | <0.1% | +379+144.1% | Added | Holders |
| Q1 2022 | 263 | $4.00K | <0.1% | +263 | New | Holders |